by James Rudge, PhD, Technical Director, Neoteryx | 6 min read
An article by Elisabeth Leere Øiestad et al at the University of Oslo and other related institutions, published in the December 2021 issue of Journal of Sustainable Chemistry and Pharmacy, …
Read Storyby James Rudge, PhD, Technical Director, Neoteryx | 6 min read
An article by Marianne Fillet et al at University of Liège in Belgium was published in the May 2021 edition of Frontiers in Molecular Biosciences. It reported on a proof-of-concept …
Read Storyby James Rudge, PhD, Technical Director, Neoteryx | 5 min read
A brief report by Ryan T. Demmer et al at the University of Minnesota, Minneapolis published in the February 2022 issue of Mayo Clinic Proceedings reported on a study measuring both …
Read Storyby James Rudge, PhD, Technical Director, Neoteryx | 6 min read
An article by Stefan Rakete et al at the Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital in Munich, Germany and three related institutions was published in …
Read Storyby James Rudge, PhD, Technical Director, Neoteryx | 5 min read
An article published by Mirjana Radovanovic et al from multiple institutions in Australia, in the January 2022 issue of the Journal of Chromatography B, reported on the development and validation …
Read Storyby James Rudge, PhD, Technical Director, Neoteryx | 6 min read
Finger-stick collection of capillary blood for dried sample analysis is a highly convenient and minimally invasive alternative to conventional phlebotomy. With the increased availability of remote specimen collection tools like …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.